Global Automated Cell Cultures Market – Industry Trends and Forecast to 2031

Automated Cell Cultures Market Analysis and Insights

The automated cell cultures market is experiencing robust growth driven by advancements in biotechnology, pharmaceutical research, and biopharmaceutical manufacturing. These automated systems play a crucial role in enhancing productivity, efficiency, and reproducibility in cell culture processes. Key factors propelling market expansion include the rising demand for high-throughput screening in drug discovery, increased focus on personalized medicine, and the need for efficient bioproduction processes. Automated cell culture systems automate tasks such as media replenishment, cell monitoring, and data analysis, thereby reducing labor costs and minimizing human error. Moreover, technological advancements such as integration with artificial intelligence (AI) and machine learning (ML) algorithms are further optimizing cell culture conditions and improving experimental outcomes.

Global automated cell cultures market size was valued at USD 12.98 billion in 2023 and is projected to reach USD 25.67 billion by 2031, with a CAGR of 8.9% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Market Definition

Automated cell cultures refer to systems and technologies that automate the processes involved in growing and maintaining cell cultures in laboratory settings. These systems typically involve automated platforms that control environmental conditions such as temperature, humidity, and CO2 levels, as well as automated handling of cell culture vessels, media changes, and monitoring of cell growth and viability.             

Automated Cell Cultures Market Dynamics

Drivers

• Rising Demand for Biopharmaceuticals        

The increasing production of biopharmaceuticals, including monoclonal antibodies and vaccines, necessitates robust and scalable cell culture systems. Automated cell culture technologies are pivotal in streamlining the manufacturing process, ensuring higher product quality, and minimizing contamination risks. These systems enhance the efficiency and reproducibility of biopharmaceutical production, making them indispensable in the industry. As the demand for biopharmaceuticals continues to grow, driven by their effectiveness and specificity in treating various diseases, the market for automated cell culture systems is expected to expand significantly.               

• Growing Investments in Life Sciences Research            

Substantial investments in life sciences research by governments, academic institutions, and private companies are driving the demand for advanced cell culture systems. Automated cell culture technologies are critical in enabling high-throughput screening and more efficient research workflows. These systems support a wide range of scientific discoveries by providing reliable and consistent cell cultures, which are essential for various research applications, including drug discovery and development. The continuous influx of funding into life sciences research underscores the importance of automated cell culture systems in advancing scientific knowledge and innovation.

Opportunities

• Expansion of Biotechnology and Pharmaceutical Industries   

The rapid growth of the biotechnology and pharmaceutical industries, fueled by the development of new drugs and therapies, is significantly increasing the need for automated cell culture systems. These industries rely on advanced cell culture technologies for various stages of drug discovery, development, and production. Automated systems offer the precision, scalability, and efficiency required to meet the high demands of these processes. As biotechnology and pharmaceutical companies continue to expand and innovate, the adoption of automated cell culture systems is expected to rise, creating opportunities for market growth.              

• Technological Advancements in Cell Culture Systems   

Continuous innovations in automated cell culture technologies, including the integration of artificial intelligence (AI) and machine learning, are revolutionizing the field. These advancements enhance the efficiency, accuracy, and scalability of cell culture processes, making them more accessible and effective for various applications. AI and machine learning algorithms optimize cell growth conditions, predict potential issues, and streamline operations, leading to more consistent and reliable outcomes. The ongoing technological advancements are driving the widespread adoption of automated cell culture systems in both research and industrial settings, contributing to market expansion.

Restraints/Challenges

• High Initial Costs for Cell Culture Systems   

The significant capital investment required for acquiring and installing automated cell culture systems poses a major barrier, particularly for smaller laboratories and research institutions. The high costs associated with purchasing the equipment, as well as the expenses related to maintenance and training, can limit market adoption. Smaller entities may struggle to justify the upfront costs despite the long-term benefits, potentially slowing down the widespread implementation of these advanced systems, and creating challenges for the market.    

• Technical Complexity of Cell Culture Systems        

The complexity of automated cell culture systems, including the need for specialized skills and expertise for their operation and maintenance, can hinder their widespread adoption. Laboratories may face significant challenges in integrating these sophisticated systems into their existing workflows. The technical demands require substantial training and adaptation, which can be daunting for some users. Overcoming these technical hurdles through user-friendly designs and comprehensive training programs is essential to facilitate broader acceptance and utilization of automated cell culture technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2024, SINFONIA TECHNOLOGY CO., LTD. announced the delivery of two units of its CellQualia Intelligent Cell Processing (ICP) System to Keio University. These systems were delivered in March and completed their Performance Qualification in April of the same year. The devices are set to support the stable production and supply of high-quality cell medicines, crucial for advancing regenerative medicine, a promising next-generation medical treatment
• In October 2023, Molecular Devices, LLC., a prominent provider of high-performance solutions in life sciences and an operating entity within Danaher Corporation's (NYSE: DHR) life sciences segment, introduced the patent-pending CellXpress.ai Automated Cell Culture System. This innovative solution integrates an incubator, liquid handler, and imager, enhanced with machine-learning capabilities

Automated Cell Cultures Market Scope

The market is segmented on the basis of products, type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Product

• Consumables
• Instruments

 Type

• Infinite Cell Line Cultures
• Finite Cell Line Cultures

 Application

• Drug Development
• Stem Cell Research
• Regenerative Medicine
• Cancer Research
• Vaccines
• Other

End User

• Biotech Companies
• Research Organizations
• Academic Research Institutes
• Other

Automated Cell Cultures Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, source, products, type, application, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to substantial investments in life sciences. This region benefits from a robust infrastructure for research and development, with significant funding directed towards lab consumables and advanced technologies. Pharmaceutical and biotechnological industries in North America are heavily investing in automated cell culture systems to enhance their research capabilities and streamline production processes.        

Asia-Pacific is expected to witness significant growth during the forecast period due to increasing productivity and investments in life sciences. Countries in this region, such as China, India, and Japan, are making significant strides in biotechnology and pharmaceutical research. Government initiatives and favorable policies aimed at boosting healthcare infrastructure and research capabilities are contributing to the market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Automated Cell Cultures Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Sartorius AG (Germany)
• Danaher (US)
• Lonza (Switzerland)
• Nexcelom Bioscience LLC (US)
• HiMedia Laboratories (India)
• Cell Culture Company, LLC (US)
• Advanced Instruments (US)
• SHIBUYA CORPORATION (Japan)
• NanoEntek (South Korea)
• FUJIFILM Holdings America Corporation (US)
• Hitachi, Ltd. (US)
• Kawasaki Heavy Industries, Ltd. (Japan)
• Sphere Fluidics Limited (UK)
• Thrive Bioscience (US)
• Eppendorf AG (Germany)
• CellGenix GmbH (Germany)
• ChemoMetec (Denmark)
• PromoCell GmbH (Germany)
• Thermo Fisher Scientific (US)
• BioSpherix, Ltd. (US)
• Merck KGaA (Germany)
• Tecan Trading AG (Switzerland)
• Hamilton Company (US)
• BD (US)
• Benchmark Scientific, Inc. (US)
• Biotron Healthcare (India)
• RWD Life Science Co., LTD (US)
• Corning Incorporated (US)
• Bulldog-Bio (US)
• Sphere Fluidics Limited (UK)

SKU-13174